Rescue Therapeutics
2012
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$3.5M
LATEST DEAL AMOUNT
3
INVESTORS
Description
Developer of a non-toxic line of drugs designed to offer treatment for cancer. The company's drugs enhance the efficacy of existing chemotherapy regimens without exposing patients to new toxicities, enabling patients to get advanced therapy for their disorder and recover faster.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 5720 Blue Ridge Drive
- College Station, TX 77845
- United States
+1 (979) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Rescue Therapeutics’s full profile, request a free trial.
Rescue Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 23-Jul-2014 | $3.5M | 00.00 | 000.00 | Completed | Generating Revenue |
Rescue Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Cheryl Cui | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Innovate Angel Funds | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| TSVC | Venture Capital | Minority | 000 0000 | 000000 0 |
Rescue Therapeutics Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Theresa Fossum Ph.D | Co-Founder, Board Member and Vice President of Preclinical Studies | ||
| James Sacchettini Ph.D | Co-Founder, Board Member and Chief Scientific Officer |
Rescue Therapeutics Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| James Sacchettini Ph.D | Rescue Therapeutics | Co-Founder, Board Member and Chief Scientific Officer | 000 0000 |